FDA 510(k)

一次性雙動作組織閉合設備

K 號：K233772 · 2024-03-19

決定日期2024-03-19

產品代碼PKL

諮詢委員會GU

決定相當於

器材摘要

Disposable Dual Action Tissue Closure Device is the device name listed in this FDA 510(k) record. The listed applicant is Mirco-Tech (Nanjing) Co., Ltd.. It received FDA 510(k) clearance on 2024-03-19 under 510(k) number K233772. The device is classified under product code PKL. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Disposable Dual Action Tissue Closure Device?

Disposable Dual Action Tissue Closure Device is a medical device that received FDA 510(k) clearance on 2024-03-19. The listed applicant is Mirco-Tech (Nanjing) Co., Ltd.. The 510(k) number is K233772.

When did Disposable Dual Action Tissue Closure Device receive FDA 510(k) clearance?

Disposable Dual Action Tissue Closure Device received FDA 510(k) clearance on 2024-03-19, under 510(k) number K233772.

Who is the listed applicant for Disposable Dual Action Tissue Closure Device?

The FDA 510(k) record lists Mirco-Tech (Nanjing) Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Disposable Dual Action Tissue Closure Device?

The FDA product code for Disposable Dual Action Tissue Closure Device is PKL.

其他以 Mirco-Tech (Nanjing) Co., Ltd. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

K260262注射針 K253832擴張氣球心导管 K254153單次使用視頻內鏡；PB數位控制器 K253139一次性遠端帽

相關器械（代碼：PKL）

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

K253481結腸FTRD組合（200.70）；診斷FTRD組合（200.76）；胃十二指腸FTRD組合（200.72）Ovesco Endoscopy AG K254069血夾（511系列，543系列）Hangzhou AGS MedTech Co., Ltd.K260580單次使用可重裝夾釘應用器（HX-810LR，HX-810UR）；夾釘（HX-610-090，HX-610-135）；長夾釘（HX-610-090L，HX-610-135L）；短夾釘（HX-610-090S，HX-610-135S）；超短夾釘（HX-610-135XS）Olympus Medical Systems Corp.K252270HemoclipHangzhou AGS MedTech Co., Ltd.K253734泰夫斯克膠片Taurus Endoscopy K251562OTSCneo 系統組合（100.03n-14n，100.27n-31n）Ovesco Endoscopy AG

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。